Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy and Attenuated Chemoradiotherapy in HPV-Positive Head and Neck Cancer
NCT02048020Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Dec 2013
- Primary completion
- Jan 2017
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Paclitaxel Micelles for Injection and carboplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Progression-free survival at 2 years. Started Dec 2013; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02048020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048020.